NB-PP_1170x120

pharmacy reimbursement

NACDS helps retail pharmacy plan for unexpected

NACDS helps retail pharmacy plan for unexpected

One of the strengths of the National Association of Chain Drug Stores is our approach to strategic planning. Specifically, each year we produce a plan that is focused, goal-oriented, member-centric, forward-thinking, efficient, effective and extremely flexible to adapt to any circumstance … to plan for the unexpected. That is exactly what is needed for NACDS

Pharmacy groups make case for pro-patient approach

WASHINGTON — Four pharmacy organizations, including the National Association of Chain Drug Stores, have asked the incoming White House administration and congressional leaders to maintain Medicare and Medicaid beneficiaries’ pharmacy access. “Policies that reduce local pharmacy access lead to poorer health outcomes, ultimately resulting in increased future health care costs,” the associations wrote to President-elect

Neighbourhood Pharmacies readies for Executive Summit

Neighbourhood Pharmacies readies for Executive Summit

TORONTO — The Neighbourhood Pharmacy Association of Canada plans to hold its Executive Summit here next month. Focusing on the changes in Canada’s prescription drug market, the event will have “The Future of Pharmacy Reimbursement” as its theme, Neighbourhood Pharmacies said. Industry leaders will provide perspectives on the evolving pharmacy landscape and current challenges to

Implications of final AMP rule for community Rx

Implications of final AMP rule for community Rx

On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule interpreting the provisions of the 2010 health care reform law that address the Medicaid Drug Rebate Program (MDRP). While much of the Final Rule speaks to drug manufacturer rights and responsibilities in the MDRP, significant portions are directly applicable

McKesson AccessHealth eyes improved Rx reimbursements

McKesson AccessHealth eyes improved Rx reimbursements

SAN FRANCISCO — McKesson AccessHealth has expanded its suite of reimbursement and performance enhancement solutions for community pharmacies. The company said that with pharmacy reimbursement models focusing more on clinical performance and patient health outcomes, it has worked with other industry leaders to develop tools, resources and webinars to help community pharmacies to improve patients’

AMP issue illustrates the pressure on Rx

AMP issue illustrates the pressure on Rx

After years of political and legal wrangling, the Centers for Medicare & Medicaid Services (CMS) has issued its final rule on Covered Outpatient Drugs, which governs reimbursement to retail pharmacies for generic medications dispensed under Medicaid. The history of the regulation goes all the way back to the Deficit Reduction Act of 2005 (DRA), which

Total Store Expo helps retailers, suppliers make connections

Total Store Expo helps retailers, suppliers make connections

DENVER — The health and wellness landscape is changing, and retailers able to navigate it will be better positioned for success. That ability and the capacity to build networks were key points made at the 2015 NACDS Total Store Expo in Denver by the National Association of Chain Drug Stores’ top two leaders. “You think

Medi-Cal looks to recoup reimbursement funds

Medi-Cal looks to recoup reimbursement funds

ARLINGTON, Va. — The National Association of Chain Drug Stores reported that Medi-Cal, California’s Medicaid program, will begin sending letters to pharmacies about recoupment of funds stemming from a reimbursement reduction that had been blocked in court and then later allowed to proceed. NACDS said the 60-day notices on funds owed to Medi-Cal will go

Community pharmacists name their priorities

Community pharmacists name their priorities

The National Community Pharmacists Association recently asked members to identify what most concerns them as 2015 gets under way. The survey results weren’t surprising, with the top issues focused on pharmacy reimbursement and preferred pharmacy networks. NCPA said the leading five priorities were maximum allowable cost (MAC) legislation to address the delay in generic drug